As of November 2024 Renovaro Biosciences has 56.27M shares outstanding, a increase of 7.11% from 2023. It represents the total number of shares of a company that are owned by all its shareholders, including both public investors and company insiders.
Year | Shares outstanding | Change |
---|---|---|
2023 | 56.27M | 7.11% |
2022 | 52.53M | 11.37% |
2021 | 47.17M | 1.81% |
2020 | 46.33M | - |